From the Guidelines
The Netoject Pen is a reusable insulin pen injector designed for precise insulin delivery, allowing patients to administer their prescribed doses subcutaneously with improved portability and ease of use. According to the recommendations for insulin delivery 1, it is essential to prime the pen before injections to ensure a free and unobstructed flow of insulin, which involves following the manufacturer's instructions and verifying a drop of insulin at the tip of the needle. Key features and guidelines for using the Netoject Pen include:
- Priming the pen before each use to ensure free flow of insulin 1
- Using the pen and its cartridges for single-person use only to prevent the risk of biologic material contamination 1
- Disposing of needles immediately after use and not leaving them attached to the pen to maintain dose accuracy 1
- Using pen needles only once, as they are no longer sterile after use 1
- Pressing the thumb button along the axis of the pen after the needle is fully inserted to ensure proper administration 1 The Netoject Pen's design supports better adherence to diabetes treatment regimens, particularly for patients requiring multiple daily insulin injections, by offering improved portability, discretion, and ease of use compared to conventional methods.
From the Research
Description of Netoject Pen
There is no information available in the provided studies about the Netoject Pen, which is Novo Nordisk's injection device.
Available Information on Injection Devices
- The studies provided focus on adrenaline auto-injectors, such as the EpiPen, and their use in treating anaphylaxis 2, 3, 4, 5, 6.
- These devices are designed for self-administration of adrenaline in emergency situations, but their use and availability are often inadequate due to various barriers 4.
- The ideal features of an adrenaline auto-injector include ease of use, portability, and accurate delivery of the life-saving drug 5.